Field Guide 
to NQF Resources

User Profiles

Learn more about how our members use NQF resources.

  • Tanya Alteras, former Deputy Director, Consumer-Purchaser Disclosure Project, National Partnership for Women & Families 
  • Christopher Dezii, Director for Healthcare Quality & Performance Measurement, Bristol-Myers Squibb
  • Jessica DiLorenzo, Program Implementation Leader, Health Care Incentives Improvement Institute (HCI3)  
  • Louis Galterio, Founder and President, SunCoast Regional Health Information Organization
  • Bill Kramer, Executive Director, National Health Policy at the Pacific Business Group on Health (PBGH)
  • Lisa Mason, Director of Cost Quality, Greater Detroit Area Health Council (GDAHC) 
  • Ann F. Monroe, President, Health Foundation for Western and Central New York


Tanya Alteras PortraitTanya Alteras, former Deputy Director, Consumer-Purchaser Disclosure Project, National Partnership for Women & Families, National Partnership for Women & Families

Tell us about the National Partnership for Women & Familes.

The National Partnership for Women & Families (NPWF) is a consumer advocacy organization that promotes access to quality, affordable health care, and policies that help women and men meet the dual demands of work and family. In my role there, I worked within the health care team as the deputy director for one of our programs, the Consumer-Purchaser Disclosure Project (CPDP). CPDP is a coalition of consumers, purchasers, and labor unions dedicated to improving the quality of health care, reducing costs, and holding providers accountable for the care they deliver.

The NPWF uses quality measurement as a strategy to create accountability. Measurement and public reporting create the structure that provides accountability and makes performance, outcome, and cost information more transparent for those who pay for and receive care.

What are the organization’s roles in consensus development and the Measure Applications Partnership (MAP)?

When measures are going through the consensus development process (CDP), NPWF reviews them and provides comments based on very deep analysis. They then provide their consumer and purchaser members with their comments so that they can engage in the process as well. They also seek out qualified consumers and purchasers to serve on NQF CDP steering committees, and provide them with support throughout the process.

NPWF also provides support for consumers and purchasers on the various Measure Applications Partnership (MAP) workgroups and task forces. They dive deeply into the measures they are being asked to review and vote on, and provide information, analysis, and rationales for why they think measures should or should not be recommended to CMS. They are very involved in NQF and MAP and use their resources often.

How does NQF impact quality measurement in health care?

NQF is a key part of the cycle of measure development, testing, and implementation. You know when a measure has been endorsed by NQF that it has gone through a very rigorous process with representatives from multiple stakeholder groups coming to consensus on that measure.

NQF has had a big role in the impact of quality measurement. They have brought together stakeholders from all corners of the health care system and opened up the dialogue on cross-cutting issues such as care coordination and the need to measure of patient-reported outcomes. They’ve been part of driving the conversation towards a more holistic look at the whole health care system.

Christopher Dezii PortraitChristopher Dezii, Director for Healthcare Quality & Performance Measurement, Bristol-Myers Squibb

Tell us more about your organization and your role in it.

I am the Director of Healthcare Quality and Performance Measures at Bristol-Myers Squibb. I have been following NQF-endorsed measures for years, and have explored QPS since its 2011 pilot. I also have participated in various NQF Technical Advisory Panels and Steering Committees. My involvement reflects the ways in which the pharmaceutical industry is evolving to support new models in health care. Our ultimate aim at Bristol-Myers Squibb is to develop medicines that improve health outcomes for people with serious diseases such as cancer, cardiovascular disease, type 2 diabetes, hepatitis, HIV/AIDS and rheumatoid arthritis and to be partners in a comprehensive plan that improves the quality of care.

What do you find most valuable about QPS?

The ability to track measures easily in QPS is invaluable. I follow the therapeutic areas relevant to my company which include measures in cardiovascular care, metabolics, oncology and rheumatology. While I have not created my own portfolios in QPS, I see how this new capability will speed access to the information I need, particularly information about the progress of measures making their way through the endorsement process or being updated.

For accuracy and relevance, QPS is a useful tool. As we develop medicines with the potential to improve the quality of existing care, we need to understand what the landscape of quality care looks like. Now and in the future, we need to be engaged. QPS provides easy access to metrics that are endorsed by multiple stakeholders and represent a stake in the ground for defining quality.

How does your organization use QPS?

We had been following a chronic anticoagulation measure which did not capture new innovations in the field. In addition to providing details on metrics, the QPS provides information on timelines and activities. As part of the public process on measure maintenance, we followed the course of discussions through the steering committee process which ultimately yielded an updated measure to reflect new options.

Back to top 

Jessica DiLorenzo PortrateJessica DiLorenzo, Program Implementation Leader, Health Care Incentives Improvement Institute (HCI3) 

Tell us more about your organization and your role in it.

HCI3 is a non-profit organization that implements a broad range of programs to measure health outcomes, promote a team approach to care, realign payment incentives around quality, and reward excellence wherever we find it. I’m responsible for the Bridges to Excellence Recognition Program implementations across the country. Bridges to Excellence® recognizes physicians, nurse practitioners and physician assistants who meet certain performance measures.

What do you find most valuable about QPS?

I’ve been using QPS since its pilot phase, and I’ve always found it very user-friendly. We work with providers, payers, EMR vendors and assessment organizations, so any tool that can help us improve alignment across these groups is a welcome addition to the toolbox. Specific features of QPS that are most valuable are the detailed search capabilities, the updates that are pushed from NQF to each portfolio owner when there are measure changes, and the functionality that allows users to find program and measure alignment across different communities.

How does your organization use QPS?

We’ve created a portfolio of all the NQF-endorsed measures we use in the Bridges to Excellence program, which includes eight clinical recognition programs for physicians including diabetes, cardiac care, asthma and COPD. We also use QPS to keep up to date on measure endorsement and to find measure alignment in locations where Bridges to Excellence is implemented. I plan to continue to refine the BTE portfolio so each BTE program has its own measure portfolio. We see our partners becoming much more interested in tools like QPS in the near future, as the EMR vendors we work with turn their attention from Meaningful Use to providing value-added services like quality measurement and reporting.

Back to top 

Louis Galterio PortrateLouis Galterio, Founder and President, SunCoast Regional Health Information Organization

Tell us about your organization and your role in it.

SunCoast is a regional health information organization (RHIO) that offers technology services, products, advice, and education to health care providers and consumers in Southwest Florida. As president and founder of SunCoast RHIO, I see helping providers and hospitals cope with the pace of change as the most important service we provide.

What do you find most valuable about QPS?

In our role as a bridge between government, research, consumer, employer, payer and provider organizations, SunCoast strives to put the latest and most accurate information about health care measurement and reporting requirements in the hands of its members. I see QPS as key to fulfilling that mission.

We face tremendous disparities in knowledge about quality reporting among our clients. All of our hospitals are using measures, but there is significant variety in terms of what people measure and why. A tool like QPS will help us get people in the region on the same page. QPS provides us a clear cut way to know which measures are best to report and an easy way to find them. 

How does your organization use QPS?

So far, I have reviewed the QPS measure portfolios shared by Pennsylvania and Maine around Meaningful Use. Looking at portfolios from other states allows me to show my members what others are doing. I look forward to having both SunCoast and local hospitals create portfolios in QPS. There is a flood of information coming out of DC and people do not know what to listen to or how to prioritize. QPS is clearly a tool that will help us cut through the clutter and get everyone moving in the same direction.

Back to top 

Bill Kramer PortraitBill Kramer, Executive Director for National Health Policy at the Pacific Business Group on Health Pacific Business Group on Health (PBGH) 

Tell us more about your organization and your role in it.

I lead PBGH’s work at the federal and state level to advance policy in ways that improve health care quality and reduce costs. I am also Co-Director of the Consumer-Purchaser Disclosure Project, a collaborative led by PBGH and the National Partnership for Women & Families to improve the quality and affordability of health care. I serve on the NQF Board, the National Priorities Partnership, the Measure Applications Partnership Coordinating Committee, and the AQA Alliance Steering Group.

Tell us about your experience/involvement with the Measure Applications Partnership (MAP).

I’m on the MAP coordinating committee and have also participated in several work groups in which the task has been to identify measures that should be used in accountability programs. The MAP advises the federal government and private sector payers on the optimal measures for use in payment and accountability programs.

How does the MAP impact quality measurement in healthcare?

Selecting the right measures to ensure that providers are providing high quality care is very important for various hospital value-based purchasing programs. It’s also of paramount importance that we select the right measures for public reporting, so that consumers have the information they need to make informed decisions about their own health care.

What would be an example of the MAP’s work in a particular area?

We’ve offered valuable input on how to measure readmissions under the Hospital Readmissions Reduction Program. What was good about the process was that all sides were heard, concerns were discussed openly, and the MAP provided a forum for those issues to be aired and for stakeholders to come to consensus about which measures should be used.

What have you found most satisfying about working with the MAP?

I’ve been involved with the MAP since its inception. I have been impressed by the high level of engagement among those involved in the coordinating committee and the work groups. There is frank discussion and debate about complex and sensitive issues and a real commitment to coming to consensus. NQF staffers do a great job managing the process, providing information and thorough analysis to committee members in ways that make our work as efficient as possible.

Back to top 

Lisa Mason PortrateLisa Mason, Director of Cost Quality, Greater Detroit Area Health Council (GDAHC) 

View GDAHC's portfolio 

Tell us about your organization and your role in it.

The Greater Detroit Area Health Council (GDAHC) is a coalition of stakeholders in healthcare, including individuals and organizations who get care, give care and who pay for care. They all work together to focus on cost, quality, and access. GDAHC hosts a provider performance reporting website, which can be found at

My role is focused on cost and quality. I work on projects that impact both of these areas. There is an enormous amount of research that says if you increase quality it will eventually decrease costs - making this a reality is what I spend every day trying to accomplish. 

Why do you think healthcare quality measurement is important?

It is all about driving improvement - getting consumers more engaged by being transparent. If we all understand the value of healthcare and how to effectively improve all aspects of it, then we can help move the entire system in the direction it should go. Having tools such as QPS to help do this will serve us all well in the short and long run.

How does your organization use QPS?

QPS helps our coalition cite meaningful measures that are proven to help positively impact care. QPS also offers us the ability to add measures we are interested in to a portfolio and search to see if others are using them also.

Why did you decide to publish your portfolio?

We like to take advantage of cutting edge ways to get and share information. We want to inspire others to use our information so we can learn from each other.

Back to top 

Ann MonroeAnn F. Monroe, President, Health Foundation for Western and Central New York 

Tell us about your organization and your role in it.

The Health Foundation for Western and Central New York is dedicated to improving the health and health care of the people and communities of western and central New York. We focus our funding and initiatives on improving health outcomes for two of the most vulnerable and underserved populations in our regions: frail elders and children living in communities of poverty. We work with community partners to develop, implement and support innovative programs and initiatives.

Tell us about your experience with the Consensus Standards Approval Committee (CSAC).

I recently chaired NQF’s Consensus Standards Approval Committee, a standing committee of the NQF Board of Directors. It is the body that makes measure endorsement recommendations to the NQF board and that has the most direct responsibility for overseeing the implementation of NQF's Consensus Development Process. We don’t determine endorsement, but we do hash out issues and assure that the NQF-adopted process was followed before measures go to the Board.

How does the CSAC impact quality measurement in healthcare?

I think you need to look broadly at NQF’s contributions, rather than CSAC’s, because CSAC is so integral to the NQF process. From a consumer perspective, standardized sets of NQF-endorsed measures such as those used in Hospital Compare and Physician Compare have allowed patients and families to make much more accurate comparisons based on public reporting than before. Tools like HCAHPs have helped to validate patient self-reporting and have given patients and families voice. While clinical measures are also important, we are still seeking the right level and type of measures to respond to consumer and purchaser priorities.

What are some of the challenges in the field of measurement today?

One of the biggest challenges moving forward is ensuring that high bar measures, especially high quality composite and outcome measures, come through the door at NQF. We have not yet figured out how to incentivize developers to create the kinds of measures we know the system needs. We need a way to stimulate that. Historically, part of the problem has been that measure developers work independently as they develop measures, leading to duplication or only incremental improvement in the measure. QPS and the upcoming measure in progress database, that will help.

What have you found most satisfying about working with the CSAC?

It’s really reinforced the power of a multi-stakeholder process for me. CSAC represents a very diverse stakeholder group, and we were able to separate our individual priorities from group priorities without burying our own values. It’s also become clear to me that measurement is in its infancy. We can look forward to great developments in this field in the years to come.

Back to top